2019 Competition Pharma Prescription 
World of DTC Marketing
DECEMBER 16, 2021
Drug sales fell across many pharma companies but cutting administrative and research costs kept earnings at industry highs. Big Pharma remains the cash king. trillion on health care in 2020, almost 10% higher than what was paid in 2019. The post Pharma industry making record profits. The bottom line: The U.S.
World of DTC Marketing
FEBRUARY 22, 2022
The Republican blockade of President Biden’s nominees for federal agencies escalated last week and now allows profit-hungry middlemen to keep prescription drug prices high. On September 19, 2019, House Speaker Nancy Pelosi introduced the Elijah Cummings Lower Drug Costs Now Act. Pharma’s attitude is “who cares?”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JANUARY 31, 2021
SUMMARY: “How big pharma takeovers destroy innovation” a report from Congresswoman Porter does make some points. I always have pointed instances in which pharma puts Wall Street first and patients second. I have worked with and stayed in contact with some R&D people within pharma and they have a different answer.
World of DTC Marketing
OCTOBER 5, 2021
Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. Big Pharma’s chokehold around the U.S. Via Axios “The 10 highest-selling drugs in the U.S.
World of DTC Marketing
DECEMBER 14, 2021
PhRMA spent pharma’s money well and bought some politicians while people who need insulin are suffering. According to the Mayo Clinic “The 3 main reasons cited by pharmaceutical companies for the high cost of new prescription drugs do not apply to insulin. Second, the pricing is not the product of a free market economy.
pharmaphorum
DECEMBER 15, 2022
A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. VPAS tax on top. .
Pharmaceutical Technology
JANUARY 30, 2023
on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. For 2019–23, this was capped at 2% per year. The post Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs appeared first on Pharmaceutical Technology.
Expert insights. Personalized for you.
205 
Let's personalize your content